Position Paper

AESGP Reply on the Evaluation and Revision of Pharma Law (2021) View
Position Paper

AESGP Reply on the Evaluation and Revision of Pharma Law (2021)

Read more
AESGP Position on Paving the way for the digitalisation of the self-care sector (2021) View
Position Paper

AESGP Position on Paving the way for the digitalisation of the self-care sector (2021)

Read more
AESGP Reply to European Commission’s Inception Impact Assessment on a European Health Emergency Preparedness and Response Authority - HERA (2021) View
Position Paper

AESGP Reply to European Commission’s Inception Impact Assessment on a European Health Emergency Preparedness and Response Authority - HERA (2021)

Read more
AESGP Position on a reinforced EMA mandate - European Health Union (2021) View
Position Paper

AESGP Position on a reinforced EMA mandate - European Health Union (2021)

Read more
AESGP Reply to European Commission’s Roadmap for the Pharmaceutical Strategy (2020) View
Position Paper

AESGP Reply to European Commission’s Roadmap for the Pharmaceutical Strategy (2020)

Read more
AESGP Position Paper on Shortages of medicinal products for citizens in Europe (2020) View
Position Paper

AESGP Position Paper on Shortages of medicinal products for citizens in Europe (2020)

Read more
AESGP Position Paper on Classification Rule 21- MDR (2020) View
Position Paper

AESGP Position Paper on Classification Rule 21- MDR (2020)

Read more
AESGP Position Paper on Antimicrobial Resistance (updated 2020) View
Position Paper

AESGP Position Paper on Antimicrobial Resistance (updated 2020)

Read more
AESGP Position Paper on Classification Rule 14 - MDR (2018) View
Position Paper

AESGP Position Paper on Classification Rule 14 - MDR (2018)

Read more
AESGP Self-Care Agenda 2020 (2016) View
Position Paper

AESGP Self-Care Agenda 2020 (2016)

Read more